CIP2A and lung carcinoma: Previous studies have shown that the overexpression of CIP2A is detected in various types of tumors, from solid tumors to hematological malignancies, including breast, gastric, head and neck, lung cancer and leukemia, and subsequently it was known as an oncofetal protein (14–17).